Cargando…
Comment on Moore et al. Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin. Diabetes Care 2013;36:2981–2987
Autor principal: | Goodarzi, Mark O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030095/ https://www.ncbi.nlm.nih.gov/pubmed/24855178 http://dx.doi.org/10.2337/dc13-2473 |
Ejemplares similares
-
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care 2013;36:2981–2987
por: Moore, EM, et al.
Publicado: (2013) -
Comment on Pepino et al. Sucralose Affects Glycemic and Hormonal Responses to an Oral Glucose Load. Diabetes Care 2013;36:2530–2535
por: Grotz, V. Lee, et al.
Publicado: (2014) -
Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Lai, Shih-Wei, et al.
Publicado: (2013) -
Response to Comment on Pepino et al. Sucralose Affects Glycemic and Hormonal Responses to an Oral Glucose Load. Diabetes Care 2013;36:2530–2535
por: Pepino, M. Yanina, et al.
Publicado: (2014) -
Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
por: Jiang, Luohua, et al.
Publicado: (2014)